New dosing strategy may boost ovulation in PCOS-Related infertility
NCT ID NCT07143682
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a step-up dose of the drug letrozole helps women with PCOS ovulate better than the standard low dose. 70 women took either the step-up or standard dose for up to 3 menstrual cycles. Researchers tracked follicle growth, uterine lining thickness, and pregnancy rates to see which approach works best.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bangabandhu Sheikh Mujib Medical University
Dhaka, 1200, Bangladesh
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can 'Abnormal' embryos still lead to healthy pregnancies? a new registry investigates
- Could a daily powder ease PCOS symptoms? a trial puts it to the test.
- Building a biological treasure trove to decode Women's health mysteries
- Ancient herb meets modern science: could ashwagandha ease PCOS symptoms?
- Can a sperm 'Quality Check' boost IVF success?
- Foam ultrasound for fertility checks: will women find it comfortable?